In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Digital health start-up Tilak raises €2.5mm in early venture round

Executive Summary

Digital health start-up Tilak Healthcare (prescribed therapeutic mobile games) raised €2.5mm ($2.7mm) in venture funding through an undisclosed early round, assumed to be its first, from the iBionext Growth Fund. Founded last year, the company is developing a mobile videogame platform used to monitor chronic diseases, with its first application targeting ophthalmology indications. Available through an app on a mobile device, the game--in which the patient completes a series of puzzles--is designed to screen for eye diseases by monitoring physician-defined visual parameters and generating remote notifications to the physician to enable prevention solutions and follow-up care. Tilak will use the proceeds to accelerate the deployment of its platform to doctors and patients.
Deal Industry
  • Digital Health
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies